Overview

Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of zoledronic acid administered at the same time with teriparatide compared to zoledronic acid alone and teriparatide alone on bone mineral density (BMD) gain in the lumbar spine and total hip
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Diphosphonates
Pharmaceutical Solutions
Teriparatide
Zoledronic Acid